Boston Therapeutics/ US63008H1023 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
2/14/2019
Boston Therapeutics Announces Official Sales and Marketing Launch of Sugardown® in Asia
GlobeNewswire
10/3/2018
Boston Therapeutics and Prevail InfoWorks Announce Strategic Clinical Partnership
GlobeNewswire
9/24/2018
Boston Therapeutics Initiates New Exploratory and Adaptive Multicenter Clinical Study of BTI320 On T...
GlobeNewswire
8/9/2018
Boston Therapeutics to launch social commerce channel for Sugardown® in China
GlobeNewswire
6/27/2018
Boston Therapeutics Introduces Sugardown® to the US under kathy Ireland® Health & Wellness
GlobeNewswire
4/16/2018
Boston Therapeutics to Hold Business Update Conference Call Wednesday, April 18, 2018 at 5:00 p.m. E...
GlobeNewswire
4/12/2018
Boston Therapeutics Announces Letter of Intent to Acquire Pennsylvania-based Medical Technology Asso...
GlobeNewswire
3/29/2018
Boston Therapeutics Engages Medical and FDA Experts: Launching New Strategic Initiatives
GlobeNewswire
1/16/2018
Boston Therapeutics, Inc. Introductory Social Media Launch (www.bostonti.com)
GlobeNewswire
12/14/2017
Boston Therapeutics, Inc. Expands Partnership with APC to Distribute in Korea